Semtech and MultiPhy Demonstrate a Complete 100G Single Lambda Chipset at ECOC 2017
Sep 18, 2017 06:00 am UTC| Business
GOTHENBURG, Sweden at The ECOC Exhibition, Sept. 18, 2017 -- Semtech Corporation (Nasdaq:SMTC), a leading supplier of high performance analog and mixed-signal semiconductors and advanced algorithms, and MultiPhy Ltd, a...
Sep 18, 2017 06:00 am UTC| Business
PITTSBURGH, Sept. 18, 2017 -- II‐VI Incorporated (NASDAQ:IIVI), a leading provider of transceiver-embedded optical amplifiers, today announced that Dr. Sanjai Parthasarathi, Vice President of Product Marketing and...
II-VI Incorporated Announces Optical Line Subsystem Platform for Datacenter Interconnects
Sep 18, 2017 06:00 am UTC| Business
PITTSBURGH, Sept. 18, 2017 -- II-VI Incorporated (NASDAQ:IIVI), a leading provider of solutions for optical networks, today announced the introduction of its Optical Line Subsystem platform for datacenter interconnects...
Inphi Announces New COLORZ®-Lite For Campus and Data Center Interconnects
Sep 18, 2017 06:00 am UTC| Business
GOTHENBURG, Sweden, Sept. 18, 2017 -- Inphi Corporation (NYSE:IPHI), a leader in high-speed data movement interconnects, today announced the expansion of its COLORZ® portfolio with COLORZ-Lite™, 100G DWDM in QSFP28 form...
Sodexo Completes Sale of Vivabox
Sep 18, 2017 05:32 am UTC| Business
Paris, September 18, 2017 -- Sodexo has completed the sale of Vivabox USA ("Vivabox") to Lion Equity Partners. Vivabox is a leading provider of products and services to the sample and subscription box industry. Vivabox is...
ThromboGenics NV : ThromboGenics Regains Global Rights to JETREA® (ocriplasmin)
Sep 18, 2017 05:31 am UTC| Business
Leuven, Belgium, 18th September, 2017 - ThromboGenics NV (Euronext Brussels: THR), a biotechnology company developing novel treatments for retinal disorders, with a focus on diabetic eye disease, announced today that it...
INNATE PHARMA, First half of 2017: delivering key clinical data and strengthening the pipeline
Sep 18, 2017 05:02 am UTC| Business
first half of 2017: DELIVERING KEY CLINICAL Data and strengthening the Pipeline Cash, cash equivalents and financial assets[1] for the Company amounted to €204.1m (million euros) as of June 30, 2017 Significant...